ÌÇÐÄvlog

This systematic review and meta-analysis examines the association between olfactory impairment and frailty.

This cohort study examines whether poor olfaction is associated with faster declines in mobility in older adults.

This case report describes a woman with lifelong anosmia in her 20s who presented with the acquisition of unpleasant olfactory phantoms.

This case-control study estimates the 3-year prevalence of measured olfactory dysfunction and gustatory dysfunction associated with SARS-CoV-2 infection.

This randomized clinical trial examines the safety and efficacy of gabapentin for patients with COVID-19–induced olfactory dysfunction.

This case-control study describes survival variables for olfactory neuroblastoma and examines the association of incorporating Hyams tumor grade into existing staging systems.

This cohort study assesses the prevalence of olfactory dysfunction and its association with frailty and postoperative outcomes in head and neck cancer.

This Viewpoint addresses the lack of reimbursement for olfactory testing, which is especially important in a time when the populations of older adults and patients with COVID-19–associated olfactory dysfunction have grown.

This randomized clinical trial assesses the efficacy of bimodal visual-olfactory training and patient-preferred scents vs unimodal olfactory training and physician-assigned scents in treatment of COVID-19 olfactory loss.

This survey study develops and validates an instrument with all relevant domains concerning chemosensory dysfunction and quality of life using modern psychometrics.

This study aims to develop and validate a concise and visually appealing smell loss–associated quality-of-life patient-reported outcome measure for olfactory dysfunction.